The global multiplex assaysmarket was valued at USD 2.61 million in 2016 and is projected to reach USD 4.84millionby 2025, growing at a CAGR of 7.1% from 2017 to 2025.
A multiplex assay is a type of assay used in research to simultaneously measure multiple analytes (dozens or more) in a single run/cycle of the assay. The market is expected to grow at a high CAGR in the forecast period due to increased applications and advantages of the technology.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Adoption of Companion Diagnostics for Increasing Safety & Efficacy of Therapies
1.2 Need for Effective Analytical Platforms to Reduce Operational Costs
1.3 Advantages of Multiplexing Over Traditional Assays
2. Market Restraints
2.1 High Investment Cost
2.2 Standardization of Immunoassay Design and Quality Control
Market Segmentation:
1. By End User:
1.1 Pharmaceutical & Biotechnology Companies
1.2 Academic & Research Institutes
1.3 Clinical Laboratories
1.4 Hospitals
1.5 Other End Users
2. By Application:
2.1 Research & Development
2.1.1 Drug Development
2.1.2 Biomarker Discovery and Validation
2.2 Disease & Disorders
2.2.1 Infectious Diseases
2.2.2 Cancer
2.2.3 Cardiac Diseases
2.2.4 Autoimmune Diseases
2.2.5 Alzheimer's Disease
2.2.6 Allergies
2.3 Companion Diagnostics
2.4 Others
3. By Product and Services:
3.1 Multiplex Assay Consumables
3.2 Multiplex Assay Instruments
3.3 Multiplex Assay Accessories
3.4 Software and Services
4. By Type:
4.1 Nucleic Acid-Based Multiplex Assays
4.1.1 Planar Nucleic Acid Assays
4.1.2 Bead-Based Nucleic Acid Assays
4.2 Protein-Based Multiplex Assays
4.2.1 Planar Protein Assays
4.2.2 Bead-Based Protein Assays
5. By Technology:
5.1 Multiplex Pcr
5.2 Multiplex Arrays
5.2.1 Multiplex Planar Arrays
5.2.2 Multiplex Bead-Based Array
5.3 Other Technologies
6. By Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Luminex Corporation
2. Thermo Fisher Scientific Inc.
3. Illumina, Inc.
4. Bio-Rad Laboratories Inc.
5. Qiagen N.V.
6. Abcam PLC
7. Becton, Dickinson and Company
8. Merck KGAA
9. Seegene Inc.
10. Meso Scale Diagnostics, LLC.
11. Randox Laboratories Ltd.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the multiplex assaysmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL MULTIPLEX ASSAYSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL MULTIPLEX ASSAYSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER
5.1 Pharmaceutical & Biotechnology Companies
5.2 Academic & Research Institutes
5.3 Clinical Laboratories
5.4 Hospitals
5.5 Other End Users
6 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION
6.1 Research & Development
6.1.1 Drug Development
6.1.2 Biomarker Discovery and Validation
6.2 Disease & Disorders
6.2.1 Infectious Diseases
6.2.2 Cancer
6.2.3 Cardiac Diseases
6.2.4 Autoimmune Diseases
6.2.5 Alzheimer's Disease
6.2.6 Allergies
6.3 Companion Diagnostics
6.4 Others
7 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICES
7.1 Multiplex Assay Consumables
7.2 Multiplex Assay Instruments
7.3 Multiplex Assay Accessories
7.4 Software and Services
8 GLOBAL MULTIPLEX ASSAYS MARKET, BY TYPE
8.1 Nucleic Acid-Based Multiplex Assays
8.1.1 Planar Nucleic Acid Assays
8.1.2 Bead-Based Nucleic Acid Assays
8.2 Protein-Based Multiplex Assays
8.2.1 Planar Protein Assays
8.2.2 Bead-Based Protein Assays
9 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
9.1 Multiplex Pcr
9.2 Multiplex Arrays
9.2.1 Multiplex Planar Arrays
9.2.2 Multiplex Bead-Based Array
9.3 Other Technologies
10 GLOBAL MULTIPLEX ASSAYSMARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
11 GLOBAL MULTIPLEX ASSAYSMARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies
12 COMPANY PROFILES
12.1 Luminex Corporation
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments
12.2 Thermo Fisher Scientific Inc.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments
12.3 Illumina, Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments
12.4 Bio-Rad Laboratories Inc.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments
12.5 Qiagen N.V.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments
12.6 Abcam PLC
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments
12.7 Becton, Dickinson and Company
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments
12.8 Merck KGAA
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments
12.9 Seegene Inc.
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Development
12.10 Meso Scale Diagnostics, LLC.
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Development
12.11 Randox Laboratories Ltd.
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Development
13 Appendix
13.1 Related Reports
The Biophysical Assays Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Biomarker Assays Development Support Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive ...
Overview of the Global Hospital-Acquired Infections Assays Market:
The report discusses everything a marketer requires before investing in the global Hospital-Acquired Infections Assays Market during the forecast pe...
The global Transport Protein Assays Kits market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market player...
The global Respiratory Panel Assays market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Cellular Health Assays market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in th...
The global Cell Viability Assays market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...
The global Protein Assays Equipment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Drug Discovery Assays market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in thi...
Overview of the Global Emerging Multiplex Diagnostic Technologies Market:
The report discusses everything a marketer requires before investing in the global Emerging Multiplex Diagnostic Technologies Market during t...